JENA, Germany and SHANGHAI, China, Feb 3, 2026 – ZEISS Medical Technology has received regulatory approval from China’s National Medical Products Administration (NMPA) for the ZEISS ARTEVO 750 and ZEISS ARTEVO 850 ophthalmic microscopes. The approval allows the systems to be used in ophthalmic surgery. The microscopes provide optical and digital visualization for both anterior and posterior eye segments and include updated hardware and software. Enhancements include higher-resolution imaging, RGB illumination, and compatibility with the newest ZEISS cataract workflow to support precision and safety during ophthalmic procedures.
“The introduction of ZEISS ARTEVO 750 and ARTEVO 850 microscopes powerfully demonstrates our commitment to ophthalmologists in China. We will leverage the power of innovation to contribute to the advancement of eye health in China and better serve Chinese surgeons and their patients,” says Martin Fischer, president & CEO of ZEISS Greater China.
The ZEISS ARTEVO 750 ophthalmic microscope was introduced in China at the 2025 China International Import Expo (CIIE). The technology supports ophthalmic procedures including cataract surgery, vitreoretinal surgery, corneal transplantation, and minimally invasive glaucoma surgery (MIGS). The ZEISS ARTEVO 750 provides optical and digital visualization and includes features such as higher resolution imaging, increased depth of field, RGB illumination, and intraoperative optical coherence tomography (OCT).
Professor Chen Jili from Shanghai Jing’an District Shibei Hospital said: “The enhanced optical resolution of the ARTEVO 750 enables us to elevate our capabilities in performing delicate ophthalmic surgeries.”
The ZEISS ARTEVO 850 is a 3D-enabled digital ophthalmic microscope designed for multiple ophthalmic specialties. The system provides digital and 3D visualization and integrates with ZEISS ophthalmic workflows. It includes features such as digital color enhancement (DCA), depth-of-field (DoF) optimization, a touchscreen control interface, and support for image reference matching and markerless toric intraocular lens implantation.
Professor Xu Gezhi from the EENT Hospital of Fudan University added: “The resolution of the ARTEVO 850 is truly excellent, and the clear visibility and reduced fatigue during the surgery make the experience very pleasant.”
The ZEISS ARTEVO 850 will be showcased at the 41st Asia-Pacific Academy of Ophthalmology (APAO) conference in Hong Kong from February 5-8, 2026.
Source: ZEISS
About ZEISS Medical Technology
Zeiss is a global optics and optoelectronics company founded in 1846 in Jena, Germany. The company is headquartered in Oberkochen, Germany. Zeiss develops and manufactures optical systems, microscopes, semiconductor manufacturing equipment, medical devices, metrology systems, and consumer optics. Its products serve industries including healthcare, life sciences, semiconductor manufacturing, industrial quality, research, and consumer vision care. Customers include hospitals, research institutions, manufacturers, and technology companies worldwide. Zeiss operates development and production sites in around 50 countries. The company employs about 46,600 people globally. Zeiss supports applications ranging from medical diagnostics and surgical systems to industrial measurement, microscopy, and optical components used in advanced manufacturing and scientific research.